Pfizer rejects link between Viagra, blindness

Following last month's report by the FDA that 38 Viagra users had gone blind as the result of non-arteritic anterior ischemic optic neuropathy, Pfizer reported that a review of all post-market optic events demonstrated that Viagra users were at no increased risk of going blind. While the agency has found no causal link between blindness and Viagra, Pfizer has agreed to report the cases on its label in order to keep physicians and patients informed.

- read this report from the AP for more

PLUS: Bayer, meanwhile, says it has not decided if it will add the information to its label for the impotence drug Levitra. One of the total of 43 cases of blindness examined by the FDA involved a man taking Levitra. Story

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.